A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Rahul Aggarwal, MD
University of California, San Francisco
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
69 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Mayo Clinic - Phoenix
Phoenix, Arizona, United States
- Sharp Memorial Hospital
Chula Vista, California, United States
- City of Hope National Medical Center
Duarte, California, United States
- Palo Alto Medical Foundation
Fremont, California, United States
- Va Central California Health Care System
Fresno, California, United States
- Sharp Memorial Hospital
La Mesa, California, United States
- Palo Alto Medical Foundation
Mountain View, California, United States
- Palo Alto Medical Foundation
Palo Alto, California, United States
- Sharp Memorial Hospital
San Diego, California, United States
- University of California San Diego - Moores Cancer Center
San Diego, California, United States
- University of California San Francisco
San Francisco, California, United States
- Palo Alto Medical Foundation
Santa Cruz, California, United States
- Adventist Health St. Helena/st. Helena Hospital/martin O'Neil Cancer Center
St. Helena, California, United States
- Palo Alto Medical Foundation
Sunnyvale, California, United States
- Georgetown University Medical Center
Washington D.C., District of Columbia, United States
- Medstar Washington Hospital Center
Washington D.C., District of Columbia, United States
- University of Hawaii Cancer Center
Honolulu, Hawaii, United States
- Pali Momi Medical Center
‘Aiea, Hawaii, United States
- Rush University Medical Center
Chicago, Illinois, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- Northshore University Health System
Evanston, Illinois, United States
- Loyola University
Maywood, Illinois, United States
- Quincy Medical Group
Quincy, Illinois, United States
- Carle Cancer Center
Urbana, Illinois, United States
- Cancer Center of Kansas
Wichita, Kansas, United States
- Eastern Maine Medical Center
Brewer, Maine, United States
- New England Cancer Specialists
Kennebunk, Maine, United States
- New England Cancer Specialists
Scarborough, Maine, United States
- New England Cancer Specialists
Topsham, Maine, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Dana Farber Cancer Institute
Milford, Massachusetts, United States
- Dana Farber Cancer Institute
South Weymouth, Massachusetts, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- Metro Minnesota Community Oncology Research Consortium
Saint Louis Park, Minnesota, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Nebraska Methodist Hospital
Omaha, Nebraska, United States
- Nevada Cancer Research Foundation
Las Vegas, Nevada, United States
- New Hampshire Oncology & Hematology
Concord, New Hampshire, United States
- New Hampshire Oncology & Hematology
Hooksett, New Hampshire, United States
- Memorial Sloan Kettering Basking Ridge
Basking Ridge, New Jersey, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Mar 2017
- Primary completion
- 25 Jun 2025
- Completion
- 25 Jun 2025
- Last update posted
- 18 Dec 2025
- Registered enrollment
- 504
- Registry id
- NCT03009981
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.